CompoAtlas

USANA PALMETTO+ CAPSULE

USANA PALMETTO+ CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL14055107T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
UHS ESSENTIAL HEALTH (MALAYSIA) SDN. BHD.
Manufacturer
USANA HEALTH SCIENCES, INC
Importer
UHS ESSENTIAL HEALTH (MALAYSIA) SDN. BHD.
Registration period starting
2024-05-11
Published validity end
2029-05-11

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Serenoa repensSerenoa repens[330mg;855mg]Not identified
Lycopersicon esculentumLycopersicon esculentum[74mg;855mg]Not identified
GLYCINE MAXGLYCINE MAX[64mg;855mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Serenoa repens[330mg;855mg],Lycopersicon esculentum[74mg;855mg],GLYCINE MAX[64mg;855mg]
Valid until
2029-05-11
Registration date
2024-05-11
Published description
NATURAL PRODUCT
Licence holder
UHS ESSENTIAL HEALTH (MALAYSIA) SDN. BHD.
Importer
UHS ESSENTIAL HEALTH (MALAYSIA) SDN. BHD.
Producer
USANA HEALTH SCIENCES, INC
Published name
USANA PALMETTO+ CAPSULE
Published reference
201310102016T
Registration number
MAL14055107T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL14055107T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Serenoa repens
    Read the warning, when it applies and the studies cited

    SAW PALMETTO – SERENOA REPENS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All subpopulations.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Adult males only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Adult females only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: Adult females only.

    Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • GLYCINE MAX
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line